ArticleBMC bioinformatics2026
SPGA: graph representation learning and attention fusion for enhanced disease-associated snoRNA prediction.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundSmall nucleolar RNAs (snoRNAs) are increasingly recognized for their involvement in human diseases. Accurate and robust prediction of disease-associated snoRNAs is crucial for accelerating drug discovery and disease treatment. However, the limited availability of biomedical data in this domain poses a significant challenge to the generalization ability of machine learning models. While existing computational methods have made progress, their performance is often constrained by data scarcity.
resultsTo overcome these limitations, we introduce SPGA, a novel graph representation learning framework designed to enhance snoRNA-disease association prediction. SPGA leverages intrinsic structural features of snoRNAs and diseases to construct interaction-aware graph representations. It then employs residual graph convolutional networks augmented with a hierarchical attention mechanism to learn robust node embeddings for association predictions. Comprehensive experiments demonstrate that SPGA effectively alleviates the data scarcity problem for model generalization and significantly improves state-of-the-art methods in terms of prediction accuracy, achieving an AUC of 0.9812 and an AUPR of 0.9749 under five-fold cross-validation setting. Case studies further validate its efficacy in identifying novel snoRNA-disease associations.
conclusionsOur study provides a potent computational tool for prioritizing candidate disease-related snoRNAs, thereby facilitating the discovery of potential diagnostic biomarkers and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.